107 related articles for article (PubMed ID: 8062353)
1. Exteroceptive suppression of temporalis muscle activity during migraine attack and migraine interval before and after treatment with sumatriptan.
Göbel H; Krapat S; Dworschak M; Heuss D; Ensink FB; Soyka D
Cephalalgia; 1994 Apr; 14(2):143-8. PubMed ID: 8062353
[TBL] [Abstract][Full Text] [Related]
2. Comparison of contingent negative variation between migraine interval and migraine attack before and after treatment with sumatriptan.
Göbel H; Krapat S; Ensink FB; Soyka D
Headache; 1993; 33(10):570-2. PubMed ID: 8294198
[TBL] [Abstract][Full Text] [Related]
3. Acetylsalicylic acid activates antinociceptive brain-stem reflex activity in headache patients and in healthy subjects.
Göbel H; Ernst M; Jeschke J; Keil R; Weigle L
Pain; 1992 Feb; 48(2):187-195. PubMed ID: 1589237
[TBL] [Abstract][Full Text] [Related]
4. Exteroceptive suppression of temporalis muscle activity: a blind study of tension-type headache, migraine, and cervicogenic headache.
Zwart JA; Sand T
Headache; 1995 Jun; 35(6):338-43. PubMed ID: 7635719
[TBL] [Abstract][Full Text] [Related]
5. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
6. Exteroceptive suppression of temporalis muscle activity: methodological and physiological aspects.
Schoenen J
Cephalalgia; 1993 Feb; 13(1):3-10. PubMed ID: 8448785
[TBL] [Abstract][Full Text] [Related]
7. Modulation of exteroceptive suppression periods in human jaw-closing muscles induced by summation of nociceptive and non-nociceptive inputs.
Romaniello A; Svensson P; Cruccu G; Arendt-Nielsen L
Exp Brain Res; 2000 Jun; 132(3):306-13. PubMed ID: 10883379
[TBL] [Abstract][Full Text] [Related]
8. Recovery cycle of the blink reflex and exteroceptive suppression of temporalis muscle activity in migraine and tension-type headache.
Aktekin B; Yaltkaya K; Ozkaynak S; Oguz Y
Headache; 2001 Feb; 41(2):142-9. PubMed ID: 11251698
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous modulation of the exteroceptive suppression periods in the trapezius and temporalis muscles by experimental muscle pain.
Ge HY; Wang K; Madeleine P; Svensson P; Sessle BJ; Arendt-Nielsen L
Clin Neurophysiol; 2004 Jun; 115(6):1399-408. PubMed ID: 15134708
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
11. Exteroceptive suppression of temporalis muscle activity in chronic headache.
Schoenen J; Jamart B; Gerard P; Lenarduzzi P; Delwaide PJ
Neurology; 1987 Dec; 37(12):1834-6. PubMed ID: 3683873
[TBL] [Abstract][Full Text] [Related]
12. Wolff Award 1992. Exteroceptive suppression of temporalis muscle activity in patients with chronic headache and in normal volunteers: methodology, clinical and pathophysiological relevance.
Schoenen J
Headache; 1993 Jan; 33(1):3-17. PubMed ID: 8436496
[TBL] [Abstract][Full Text] [Related]
13. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
14. Modulation of masseter exteroceptive suppression by non-nociceptive upper limb afferent activation in humans.
Deriu F; Milia M; Sau G; Podda MV; Ortu E; Giaconi E; Aiello I; Tolu E
Exp Brain Res; 2003 May; 150(2):154-62. PubMed ID: 12677317
[TBL] [Abstract][Full Text] [Related]
15. Cerebral blood flow during migraine attacks without aura and effect of sumatriptan.
Ferrari MD; Haan J; Blokland JA; Arndt JW; Minnee P; Zwinderman AH; Pauwels EK; Saxena PR
Arch Neurol; 1995 Feb; 52(2):135-9. PubMed ID: 7848120
[TBL] [Abstract][Full Text] [Related]
16. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
[TBL] [Abstract][Full Text] [Related]
17. [Exteroceptive suppression of activity of the temporal muscle. Principles and applications].
Göbel H; Dworschak M
Nervenarzt; 1996 Oct; 67(10):846-59. PubMed ID: 9036358
[TBL] [Abstract][Full Text] [Related]
18. Exteroceptive suppression of temporalis muscle activity in various types of headache.
Paulus W; Raubüchl O; Straube A; Schoenen J
Headache; 1992 Jan; 32(1):41-4. PubMed ID: 1555931
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice.
Russell MB; Holm-Thomsen OE; Rishøj Nielsen M; Cleal A; Pilgrim AJ; Olesen J
Cephalalgia; 1994 Aug; 14(4):291-6. PubMed ID: 7954759
[TBL] [Abstract][Full Text] [Related]
20. Change in the second exteroceptive suppression period of the temporalis muscle during erenumab treatment.
Rota E; Aguggia M; Immovilli P; Morelli N; Renosio D; Barbanera A
Naunyn Schmiedebergs Arch Pharmacol; 2022 May; 395(5):607-611. PubMed ID: 35179620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
